CT and MRI Early Vessel Signs Reflect Clot Composition in Acute Stroke

Background and Purpose— The purpose of this study was to provide the first correlative study of the hyperdense middle cerebral artery sign (HMCAS) and gradient-echo MRI blooming artifact (BA) with pathology of retrieved thrombi in acute ischemic stroke. Methods— Noncontrast CT and gradient-echo MRI studies before mechanical thrombectomy in 50 consecutive cases of acute middle cerebral artery ischemic stroke were reviewed blinded to clinical and pathology data. Occlusions retrieved by thrombectomy underwent histopathologic analysis, including automated quantitative and qualitative rating of proportion composed of red blood cells (RBCs), white blood cells, and fibrin on microscopy of sectioned thrombi. Results— Among 50 patients, mean age was 66 years and 48% were female. Mean (SD) proportion was 61% (±21) fibrin, 34% (±21) RBCs, and 4% (±2) white blood cells. Of retrieved clots, 22 (44%) were fibrin-dominant, 13 (26%) RBC-dominant, and 15 (30%) mixed. HMCAS was identified in 10 of 20 middle cerebral artery stroke cases with CT with mean Hounsfield Unit density of 61 (±8 SD). BA occurred in 17 of 32 with gradient-echo MRI. HMCAS was more commonly seen with RBC-dominant and mixed than fibrin-dominant clots (100% versus 67% versus 20%, P=0.016). Mean percent RBC composition was higher in clots associated with HMCAS (47% versus 22%, P=0.016). BA was more common in RBC-dominant and mixed clots compared with fibrin-dominant clots (100% versus 63% versus 25%, P=0.002). Mean percent RBC was greater with BA (42% versus 23%, P=0.011). Conclusions— CT HMCAS and gradient-echo MRI BA reflect pathology of occlusive thrombus. RBC content determines appearance of HMCAS and BA, whereas absence of HMCAS or BA may indicate fibrin-predominant occlusive thrombi.

[1]  N. Salamon,et al.  Autopsy Findings After Intracranial Thrombectomy for Acute Ischemic Stroke: A Clinicopathologic Study of 5 Patients , 2010, Stroke.

[2]  D. Liebeskind Reperfusion for acute ischemic stroke: arterial revascularization and collateral therapeutics , 2010, Current opinion in neurology.

[3]  Penumbra Pivotal Stroke Trial Investigators The Penumbra Pivotal Stroke Trial: Safety and Effectiveness of a New Generation of Mechanical Devices for Clot Removal in Intracranial Large Vessel Occlusive Disease , 2009, Stroke.

[4]  D. Liebeskind Venous hemodynamics may enhance collateral perfusion and the fibrinolytic milieu in paradoxical embolism. , 2009, Stroke.

[5]  M. Hill,et al.  Calcification and endothelialization of thrombi in acute stroke , 2008, Annals of neurology.

[6]  H. Lutsep,et al.  Mechanical Thrombectomy for Acute Ischemic Stroke: Final Results of the Multi MERCI Trial , 2008, Stroke.

[7]  G. Schroth,et al.  Comparison of Intraarterial and Intravenous Thrombolysis for Ischemic Stroke With Hyperdense Middle Cerebral Artery Sign , 2008, Stroke.

[8]  P. Vespa,et al.  Analysis of Thrombi Retrieved From Cerebral Arteries of Patients With Acute Ischemic Stroke , 2006, Stroke.

[9]  W. Smith,et al.  Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, part I. , 2006, AJNR. American journal of neuroradiology.

[10]  A. Divani,et al.  Is IV tissue plasminogen activator beneficial in patients with hyperdense artery sign? , 2006, Neurology.

[11]  K. Willmes,et al.  The hyperdense posterior cerebral artery sign: a computed tomography marker of acute ischemia in the posterior cerebral artery territory. , 2006, Stroke.

[12]  P. Vespa,et al.  Analysis of Thrombi Retrieved from Cerebral Arteries of Patients with Acute Ischemic Stroke. , 2005 .

[13]  C. Molina Imaging the clot: does clot appearance predict the efficacy of thrombolysis? , 2005, Stroke.

[14]  S. Kwon,et al.  Significance of Susceptibility Vessel Sign on T2*-Weighted Gradient Echo Imaging for Identification of Stroke Subtypes , 2005, Stroke.

[15]  D. Liebeskind Collaterals in acute stroke: beyond the clot. , 2005, Neuroimaging clinics of North America.

[16]  H. Chabriat,et al.  Intra-Arterial Thrombus Visualized on T2* Gradient Echo Imaging in Acute Ischemic Stroke , 2005, Cerebrovascular Diseases.

[17]  D. Liebeskind,et al.  Advanced MR imaging of acute stroke: the University of California at Los Angeles endovascular therapy experience. , 2005, Neuroimaging clinics of North America.

[18]  T. Brott,et al.  Approval of the MERCI clot retriever: a critical view. , 2005, Stroke.

[19]  Gianfranco Chiari,et al.  Clinical Usefulness of Computed Tomography Study Without Contrast Injection in the Evaluation of Acute Pulmonary Embolism , 2005, Journal of computer assisted tomography.

[20]  P. Lyden,et al.  Thrombosis of the posterior cerebral artery (PCA) visualized on computed tomography: the dense PCA sign. , 2004, Archives of neurology.

[21]  Fernando Vinuela,et al.  MERCI 1: A Phase 1 Study of Mechanical Embolus Removal in Cerebral Ischemia , 2004, Stroke.

[22]  À. Rovira,et al.  Hyperacute ischemic stroke: middle cerebral artery susceptibility sign at echo-planar gradient-echo MR imaging. , 2004, Radiology.

[23]  Steven Warach,et al.  Trial design and reporting standards for intraarterial cerebral thrombolysis for acute ischemic stroke. , 2003, Journal of vascular and interventional radiology : JVIR.

[24]  R. Higashida,et al.  Trial Design and Reporting Standards for Intra-Arterial Cerebral Thrombolysis for Acute Ischemic Stroke , 2003, Stroke.

[25]  K. Sartor,et al.  Differentiation of white, mixed, and red thrombi: value of CT in estimation of the prognosis of thrombolysis phantom study. , 2003, Radiology.

[26]  K. Muir,et al.  What Constitutes a True Hyperdense Middle Cerebral Artery Sign? , 2000, Cerebrovascular Diseases.

[27]  N. Petitti The hyperdense middle cerebral artery sign. , 1998, Radiology.

[28]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[29]  D. Leys,et al.  Prevalence and Significance of Hyperdense Middle Cerebral Artery in Acute Stroke , 1992, Stroke.

[30]  A. Fox,et al.  Hyperdense middle cerebral artery sign on CT: efficacy in detecting middle cerebral artery thrombosis. , 1990, AJNR. American journal of neuroradiology.

[31]  A. Fox,et al.  CT visualization of intracranial arterial thromboembolism. , 1983, Stroke.

[32]  T. Brott,et al.  Hyperdense middle cerebral artery: incidence and quantitative significance , 2004, Neuroradiology.

[33]  J. Broderick,et al.  Prognostic value of the hyperdense middle cerebral artery sign and stroke scale score before ultraearly thrombolytic therapy. , 1996, AJNR. American journal of neuroradiology.

[34]  Nirds,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group , 1995 .

[35]  W Hacke,et al.  Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk. , 1994, AJNR. American journal of neuroradiology.

[36]  W. Schaper,et al.  Collateral Circulation , 1993, Springer US.

[37]  L. Bozzao,et al.  Hyperdense middle cerebral artery CT sign. Comparison with angiography in the acute phase of ischemic supratentorial infarction. , 1991, Neuroradiology.